Photo from Matthias Guckenberger/Twitter
Aug 19, 2023, 19:07
Matthias Guckenberger: First esophageal cancer patient enrolled into randomized protect trial.
Matthias Guckenberger, the Chairman and a Professor of the Department of Radiation Oncology at the University Hospital Zurich, wrote in a recent post:
”First oesophageal cancer patient enrolled into randomized protect trial, comparing neoadjuvant Photon or Proton radiochemotherapy. Strong collaboration between The Paul Scherrer Institute and The Radiooncology Department of the University Hospital Zurich, Comprehensive Cancer Center Zurich.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46